Published in Ann Intern Med on May 01, 1991
Short-course Methenamine Hippurate for Prevention of Post-operative UTI (NO-UTI) | NCT02358993
Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ (2013) 3.72
Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol (2005) 1.52
Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control (2004) 1.32
Management of catheter-associated urinary tract infection. Curr Opin Infect Dis (2010) 1.19
Is presence of bacteria in preoperative microscopic urinalysis of the patients scheduled for cardiac surgery a reason for cancellation of elective operation? Anesth Pain Med (2013) 0.82
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother (1993) 0.81
Standards of therapy for urinary tract infections in adults. Infection (1992) 0.81
Assessing the effect of community health nursing care management at home on war-worn soldiers' physical problems suffering from spinal cord complications (urinary infection, bedsore). Iran J Nurs Midwifery Res (2010) 0.75
Evaluation of the Cult-Dip Plus dip slide method for urinary tract infection. J Clin Pathol (1995) 0.75
Antibiotic Prophylaxis in Radical Prostatectomy: Comparison of 2-Day and More than 2-Day Prophylaxis. J Korean Med Sci (2017) 0.75
Single dose treatment failure in women with acute cystitis. Infection (1992) 0.75
Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet (1989) 11.39
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05
A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med (1966) 5.80
Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85
AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68
Male circumcision: assessment of health benefits and risks. Sex Transm Infect (1998) 4.59
Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med (1988) 4.55
Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol (1978) 4.20
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol (1990) 3.63
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS (1989) 3.48
A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ (1998) 3.46
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother (1978) 3.23
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.19
Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis (1981) 2.89
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant (2009) 2.57
Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med (1987) 2.48
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Determination of the hemin requirement of Haemophilus ducreyi: evaluation of the porphyrin test and media used in the satellite growth test. J Clin Microbiol (1978) 2.37
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet (1988) 2.33
Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother (2000) 2.22
Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med (1988) 2.20
Bacteriuria in elderly institutionalized men. N Engl J Med (1983) 2.20
Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J (1984) 2.13
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis (1994) 2.09
Problems with rapid agglutination methods for identification of Staphylococcus aureus when Staphylococcus saprophyticus is being tested. J Clin Microbiol (1988) 2.09
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05
Chlamydia trachomatis, infertility, and population growth in sub-Saharan Africa. Sex Transm Dis (1993) 2.05
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) (1966) 1.99
Infectious diseases as a Canadian subspecialty, with projections to the year 2000. Rev Infect Dis (1990) 1.99
Bacteriuria localization and response to single-dose therapy in women. JAMA (1976) 1.98
The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc (1996) 1.97
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis (1983) 1.92
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med (2006) 1.91
Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis (1985) 1.91
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother (2000) 1.89
The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis (1996) 1.88
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Quantification of the placebo response in ulcerative colitis. Gastroenterology (1997) 1.86
Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis (1994) 1.85
Plasmid-mediated ampicillin resistance in Haemophilus ducreyi. Antimicrob Agents Chemother (1979) 1.85
Kanamycin sulfate in the treatment of acute gonorrheal urethritis in men. JAMA (1968) 1.84
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
Resistance of gram-negative bacilli to gentamicin. J Infect Dis (1971) 1.82
Characterization of coagulase-negative staphylococci from urinary tract specimens. J Clin Microbiol (1983) 1.81
The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis (1994) 1.79
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med (1974) 1.74
Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother (1996) 1.74
In utero exposure to diagnostic ultrasound: a 6-year follow-up. Radiology (1988) 1.71
Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya. J Infect Dis (1992) 1.70
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol (2006) 1.69
Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet (1993) 1.68
Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol (1992) 1.67
Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis (1996) 1.67
Influence of mucoidy on antibody coating of Pseudomonas aeruginosa. J Infect Dis (1979) 1.67
Epidemiology of ophthalmia neonatorum in Kenya. Lancet (1986) 1.66
Characterization of cell proteins of Haemophilus ducreyi by polyacrylamide gel electrophoresis. J Infect Dis (1983) 1.65
A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med (1979) 1.64
Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus. J Clin Microbiol (1992) 1.62
Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol (1997) 1.61
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1990) 1.59
Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection. Lancet (1982) 1.58
Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet (1983) 1.57
A randomized, placebo-controlled trial of monthly azithromycin prophylaxis to prevent sexually transmitted infections and HIV-1 in Kenyan sex workers: study design and baseline findings. Int J STD AIDS (2000) 1.55
Relationship between lipopolysaccharide composition and virulence of Haemophilus ducreyi. J Med Microbiol (1987) 1.55
Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol (1998) 1.54
Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis (2005) 1.54